Compounds > troglitazone

Page last updated: 2024-08-16

troglitazone and cisapride

troglitazone has been researched along with cisapride in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (54.55)	29.6817
2010's	5 (45.45)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
SoRelle, R	1
Greene, HL	1
Terpening, CM	1
South, D	1
Cady, PS; Force, RW; Wilkinson, JJ	1

Other Studies

11 other study(ies) available for troglitazone and cisapride

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Drugs and disease. Circulation, 2000, Apr-04, Volume: 101, Issue:13 Topics: Chromans; Cisapride; Diabetes Mellitus, Type 2; Drug and Narcotic Control; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone	2000
From the Food and Drug Administration. JAMA, 2000, May-03, Volume: 283, Issue:17 Topics: Anti-Infective Agents, Local; Bacterial Vaccines; Bandages; Chromans; Cisapride; Drug and Narcotic Control; Drug Approval; Equipment Contamination; Gastrointestinal Agents; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Hypoglycemic Agents; Infant; Meningococcal Vaccines; Pneumococcal Vaccines; Streptococcus pneumoniae; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration; Vaccines, Conjugate	2000
Drug recalls underscore safety concerns. Health news (Waltham, Mass.), 2000, Volume: 6, Issue:5 Topics: Arrhythmias, Cardiac; Chromans; Cisapride; Drug and Narcotic Control; Gastrointestinal Agents; Humans; Hypoglycemic Agents; Liver Failure; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2000
The FDA: protector or puppet? Pharmacotherapy, 2000, Volume: 20, Issue:7 Topics: Chromans; Cisapride; Drug and Narcotic Control; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Tobacco Industry; Troglitazone; United States; United States Food and Drug Administration	2000
Plaintiff's attorney actively seeking out patients who have used various FDA approved medications and who "may be entitled to compensation for damages caused by these medications". Journal of the Mississippi State Medical Association, 2000, Volume: 41, Issue:11 Topics: Chromans; Cisapride; Gastrointestinal Agents; Humans; Hypoglycemic Agents; Liability, Legal; Malpractice; Mississippi; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2000
Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone. Pharmacotherapy, 2004, Volume: 24, Issue:8 Topics: Chromans; Cisapride; Databases, Factual; Drug Labeling; Gastrointestinal Agents; Humans; Hypoglycemic Agents; Pharmacoepidemiology; Product Surveillance, Postmarketing; Retrospective Studies; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2004